NASDAQ:IDRA Idera Pharmaceuticals, Inc
$IDRA Recent insider buying, a indication. Big news may be released soon. Mutli-phase trials of Tilsotolimod. ILLUMINATE-206 phase 2 results expected soon. Low float and high rel vol w/ a large gap to fill.